San Diego, CA, United States of America

Michael Croft

USPTO Granted Patents = 15 


 

Average Co-Inventor Count = 2.8

ph-index = 8

Forward Citations = 226(Granted Patents)


Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Croft

Introduction

Michael Croft, an accomplished inventor based in San Diego, CA, has made significant strides in the field of immunology. With a remarkable portfolio of 15 patents to his name, Croft's work focuses on the development of monoclonal antibodies, which are crucial for advancing therapeutic methods.

Latest Patents

Among his latest innovations is the patent for the human monoclonal antibody human CD134 (OX40) and methods of making and using the same. This invention provides antibodies that specifically bind to OX40 (CD134), known as OX40 antibodies, anti-OX40, or anti-OX40 antibodies. These innovative antibodies include various forms such as mammalian (human, primate, etc.), humanized, and chimeric anti-OX40 antibodies. Furthermore, the invention encompasses purified and isolated antibody fragments that specifically target OX40, along with pharmaceutical formulations. The applications of these antibodies are extensive, facilitating methods in treatment, screening, and detection.

Career Highlights

Throughout his career, Michael Croft has held pivotal roles at respected institutions such as the La Jolla Institute for Allergy and Immunology and Kyowa Hakko Kirin Co., Limited. His work at these organizations has not only contributed to his personal portfolio of patents but has also advanced the field of immunological research significantly.

Collaborations

Croft's journey in innovation has been enriched by collaborations with notable colleagues, including Shahram Salek-Ardakani and Shinichiro Kato. These partnerships have fostered a creative environment conducive to groundbreaking discoveries in antibody development and therapeutic applications.

Conclusion

Michael Croft stands out as a significant figure in the realm of immunology and patent innovation. With his remarkable contributions to the field through his numerous patents, he continues to drive advancements in treatments that leverage the power of monoclonal antibodies. His work not only showcases the importance of innovation in science but also highlights the collaborative effort required to achieve success in such a complex domain.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…